Search Results | Scholarly Articles, Journals, and E-Books

Results: 5

Subacute thyroiditis following COVID-19 vaccination: Case presentation.
Published in:
Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231208831
By:
- Tomic, Aleksandra Z.;
- Zafirovic, Sonja S.;
- Gluvic, Zoran M.;
- Samardzic, Vladimir S.;
- Macvanin, Mirjana T.;
- Radunovic, Maja L. J.;
- Isenovic, Esma R.
Publication type:
Article
Andrographolide inhibits infectious bronchitis virus-induced apoptosis, pyroptosis, and inflammation.
Published in:
Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231207499
By:
- Jiachen Shen;
- Qiuchi Xu;
- Lu Chen;
- Xinyu Chang;
- Ruiting Shen;
- Zhenhua Zhao;
- Lifei Zhu;
- Yifei Wu;
- Xiaolin Hou
Publication type:
Article
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach.
Published in:
Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231199838
By:
- Elkaeed, Eslam B.;
- Alsfouk, Bshra A.;
- Ibrahim, Tuqa H.;
- Arafa, Reem K.;
- Elkady, Hazem;
- Ibrahim, Ibrahim M.;
- Eissa, Ibrahim H.;
- Metwaly, Ahmed M.
Publication type:
Article
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
Published in:
Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231201162
By:
- Carr, Andrew;
- Mackie, Nicola E.;
- Paredes, Roger;
- Ruxrungtham, Kiat
Publication type:
Article
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.
Published in:
Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231195431
By:
- Bassel, Marielle;
- Romanus, Dorothy;
- Tien Bo;
- Sundberg, Aimee K.;
- Okala, Sandra;
- Hirji, Ishan
Publication type:
Article

Subacute thyroiditis following COVID-19 vaccination: Case presentation.

Andrographolide inhibits infectious bronchitis virus-induced apoptosis, pyroptosis, and inflammation.

Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach.

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.

Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.